The study found no increased risk of cancer, deep vein thrombosis or stroke.

FORBES: Connect

As a chronic deep vein thrombosis sufferer I would like to make one or two points in relation to your programme last night on deep vein thrombosis.

BBC: Your comments on Economy Class Syndrome

The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment.

FORBES: Rivaroxaban Gains FDA Indications For The Treatment And Prevention Of DVT And PE

The label now includes a black box warning that it can increase the risk of death, MI, stroke, venous thromboembolism, thrombosis of vascular access, and tumor progression or recurrence.

FORBES: Amgen Pleads Guilty To Misbranding Anemia Drug Aranesp